Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 4997

BillFederalSenateIn Committee
A bill to set forth requirements for the regulation by the Food and Drug Administration of nitrous oxide products, and for other purposes.
About This Bill
Committee
Latest Action · July 15, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
119th (2025–2027)
Introduced
July 15, 2026
Cosponsors (2)
2D 0R
View PDF ↗

Summary

Highlight any text to annotate
The Nitrous Oxide Inhalation Prevention Act directs the Food and Drug Administration to regulate nitrous oxide products sold for non-medical use while preserving access for legitimate medical, dental, industrial, and automotive purposes. The bill establishes strict packaging and labeling requirements including prominent warning labels covering at least 20 percent of product packaging, bans flavored nitrous oxide products, limits individual canister size to 8 grams for food use, and restricts sales to individuals under 21 years old with age verification requirements. The law also prohibits sales between 10 p.m. and 5 a.m., requires products to be stored in locked areas out of public view, and sets purchase limits on individual consumers. Additionally, the bill authorizes grants to nonprofit organizations, schools, law enforcement, and health facilities to conduct education campaigns and training programs on the dangers of nitrous oxide misuse, with the FDA required to issue implementing regulations within one year and submit annual enforcement reports to Congress. Funding is authorized through fiscal year 2036 with unspecified appropriations amounts.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.